DIN 02558238 — YESAFILI 2 MG
YESAFILI is a solution of Aflibercept marketed by BIOCON BIOLOGICS CANADA INC. The full Aflibercept monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02558238
- Brand name
- YESAFILI
- Active ingredient
- Aflibercept
- Strength
- 2 MG
- Dosage form
- SOLUTION
- Route
- INTRAVITREAL
- Manufacturer
- BIOCON BIOLOGICS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Vascular endothelial growth factor (VEGF) inhibitor (anti-angiogenic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Aflibercept products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02554178 | AFLIVU | 2 MG | SOLUTION | APOTEX INC | MARKETED |
| 02554194 | AFLIVU | 2 MG | SOLUTION | APOTEX INC | MARKETED |
| 02562510 | ENZEEVU | 2 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02563037 | EYDENZELT | 2 MG | SOLUTION | CELLTRION INC. | MARKETED |
| 02563045 | EYDENZELT | 2 MG | SOLUTION | CELLTRION INC. | MARKETED |
| 02415992 | EYLEA | 2 MG | SOLUTION | BAYER INC | MARKETED |
| 02505355 | EYLEA | 2 MG | SOLUTION | BAYER INC | MARKETED |
| 02545004 | EYLEA HD | 8 MG | SOLUTION | BAYER INC | MARKETED |
| 02554798 | EYLEA HD | 8 MG | SOLUTION | BAYER INC | MARKETED |
| 02550636 | PAVBLU | 2 MG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02535858 | YESAFILI | 2 MG | SOLUTION | BIOCON BIOLOGICS CANADA INC | MARKETED |